Mustafa Khalid AbdulJabbar, Susan Saab Manfi Al-Rawi, Bilal Khaleel Midhin, Roghayeh Mohammadzadeh, Raad N Hasan, Mobina Kouhzad, Nasrin Alanchari, Erta Rajabi
{"title":"C. difficile Infection in Colorectal Cancer: Risk Determinants, Outcomes, and Evolving Management Approaches.","authors":"Mustafa Khalid AbdulJabbar, Susan Saab Manfi Al-Rawi, Bilal Khaleel Midhin, Roghayeh Mohammadzadeh, Raad N Hasan, Mobina Kouhzad, Nasrin Alanchari, Erta Rajabi","doi":"10.1007/s12029-025-01321-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and poses a considerable public health challenge; concurrently, Clostridioides difficile infection (CDI) represents a significant hospital-acquired infection, with a rising incidence observed among cancer patients.</p><p><strong>Aim: </strong>To examine the relationship between CDI and CRC, it will address the risk factors associated with CDI in patients with CRC, clinical outcomes, recent findings regarding the influence of CDI on CRC, and the current strategies for management.</p><p><strong>Results: </strong>Risk factors including gut microbiota dysbiosis, surgical interventions, chemotherapy, immunotherapy, prolonged hospitalization, and antibiotic exposure elevate susceptibility to CDI in CRC patients. Additionally, CDI correlates with more complex treatment regimens and longer hospital stays in this demographic. Furthermore, recent studies indicate that the incidence of CDI may increase the risk of CRC development.</p><p><strong>Conclusion: </strong>The prevention, diagnosis, and treatment of CDI in CRC patients are critical for enhancing outcomes. A comprehensive understanding of the bidirectional relationship between CDI and CRC can guide the development of management strategies for this important clinical issue.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"56 1","pages":"200"},"PeriodicalIF":1.6000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastrointestinal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12029-025-01321-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and poses a considerable public health challenge; concurrently, Clostridioides difficile infection (CDI) represents a significant hospital-acquired infection, with a rising incidence observed among cancer patients.
Aim: To examine the relationship between CDI and CRC, it will address the risk factors associated with CDI in patients with CRC, clinical outcomes, recent findings regarding the influence of CDI on CRC, and the current strategies for management.
Results: Risk factors including gut microbiota dysbiosis, surgical interventions, chemotherapy, immunotherapy, prolonged hospitalization, and antibiotic exposure elevate susceptibility to CDI in CRC patients. Additionally, CDI correlates with more complex treatment regimens and longer hospital stays in this demographic. Furthermore, recent studies indicate that the incidence of CDI may increase the risk of CRC development.
Conclusion: The prevention, diagnosis, and treatment of CDI in CRC patients are critical for enhancing outcomes. A comprehensive understanding of the bidirectional relationship between CDI and CRC can guide the development of management strategies for this important clinical issue.
期刊介绍：
The Journal of Gastrointestinal Cancer is a multidisciplinary medium for the publication of novel research pertaining to cancers arising from the gastrointestinal tract.The journal is dedicated to the most rapid publication possible.The journal publishes papers in all relevant fields, emphasizing those studies that are helpful in understanding and treating cancers affecting the esophagus, stomach, liver, gallbladder and biliary tree, pancreas, small bowel, large bowel, rectum, and anus. In addition, the Journal of Gastrointestinal Cancer publishes basic and translational scientific information from studies providing insight into the etiology and progression of cancers affecting these organs. New insights are provided from diverse areas of research such as studies exploring pre-neoplastic states, risk factors, epidemiology, genetics, preclinical therapeutics, surgery, radiation therapy, novel medical therapeutics, clinical trials, and outcome studies.In addition to reports of original clinical and experimental studies, the journal also publishes: case reports, state-of-the-art reviews on topics of immediate interest or importance; invited articles analyzing particular areas of pancreatic research and knowledge; perspectives in which critical evaluation and conflicting opinions about current topics may be expressed; meeting highlights that summarize important points presented at recent meetings; abstracts of symposia and conferences; book reviews; hypotheses; Letters to the Editors; and other items of special interest, including:Complex Cases in GI Oncology: This is a new initiative to provide a forum to review and discuss the history and management of complex and involved gastrointestinal oncology cases. The format will be similar to a teaching case conference where a case vignette is presented and is followed by a series of questions and discussion points. A brief reference list supporting the points made in discussion would be expected.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
